Logo

Liquid Biopsy

News and reporting on cell-free DNA testing.

Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA
Premium

The firm plans to ramp up US commercialization following the study, while continuing to develop its cell-free RNA diagnostic platform.

VolitionRx Bets on Canine Cancer Screening Test as Nucleosome Tech Development Continues
Premium

The company recently signed on Heska for selling its Nu.Q Vet Cancer Screening Test at the point of care, and Sage Healthcare as a distributor in Singapore.

Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology

The partners' first project is an expansion of Delfi's previously announced prospective study of its blood-based screening assay in patients with a high risk of lung cancer.

Mirvie Raises $60M in Series B Funding

The company plans to use the funding to propel the clinical and commercial development of its Mirvie RNA testing platform for pregnancy health.

Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program
Premium

The test is first available to employees over age 50 covered under Intermountain's SelectHealth, but the health system has a bigger five-year plan.

May 9, 2022

Artemis DNA to Provide Datar Cancer Genetics Liquid Biopsy Tests in the US, Vietnam Under $250M Deal

May 9, 2022

Guardant Health Confident in New CRC Screening Blood Test Despite Competitor Skepticism
Premium

May 9, 2022

Delfi Diagnostics Begins Second, Larger Prospective Lung Cancer Screening Trial

May 6, 2022

Illumina Provides Updates on China Business, Grail, Upcoming Sequencing Chemistries
Premium

May 6, 2022

Personalis Building Data for High-Sensitivity Residual Cancer Assay
Premium

May 6, 2022

Tempus to Provide NGS Cancer Tests to US Department of Veterans Affairs

May 5, 2022

Illumina Q1 Revenues Grow 12 Percent

May 5, 2022

Guardant Health Q1 Revenues up 22 Percent

May 5, 2022

Enumera Molecular Acquires Progenity Liquid Biopsy Tech, Raises $12.5M in Series A Round

May 4, 2022

BioMark Diagnostics Raises C$1.5M to Commercialize Lung Cancer Liquid Biopsy Test

May 4, 2022

Bio-Techne Fiscal Q3 Revenues Rise 19 Percent

Apr 29, 2022

Exai Bio Commercializing Noncoding RNA Method for Liquid Biopsy Applications
Premium

Apr 29, 2022

St. Jude Program Installing Nanopore Sequencing in Low-Income Countries to Diagnose Pediatric Blood Cancers
Premium

Apr 28, 2022

As Competing Blood-Based Cancer Screening Tests Loom, Exact Sciences Stresses Cologuard Advantage
Premium

Apr 28, 2022

Mirvie Developing Cell-Free RNA Blood Tests to Predict Pregnancy Complications
Premium

Apr 27, 2022

NeoGenomics Looking to 2022 as Rebuilding Year as It Seeks New CEO, Expands NGS Offering
Premium

Apr 27, 2022

PetDx-led Team Clinically Validates Liquid Biopsy Test for Canine Cancers

Apr 25, 2022

VolitionRx Signs on Sage Healthcare as Distributor for Canine Cancer Test in Asia

Apr 25, 2022

NeoGenomics, Eli Lilly to Offer Molecular Testing to Non-Small Cell Lung Cancer Patients

Apr 21, 2022

Consensus Builds for Real-World Evidence to Support Multi-Cancer Screening Tests
Premium

Breaking News
The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.